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fiGeographical Mystery:
o Cardiotropic Viruses
espect National Borders?
e read the interesting article of Andréoletti et al. (1) showing
ctive coxsackieviral B (CV-B) infection in post-mortem endo-
yocardial tissue of patients who died suddenly due to acute
yocardial infarction. The demonstration of sarcolemmal dystro-
hin disruption in the same tissue areas that were infected by
V-B is of potential groundbreaking value for the understanding
f viral pathogen-induced myocardial damage in humans. Both
V-B genomes and CV-B capsid proteins were detected in the
eart tissues of patients with myocardial infarction by reverse
ranscriptase-polymerase chain reaction and immunohistochemis-
ry, thereby suggesting active virus replication.
However, it is interesting to find that about one-half of the
yocytes (exemplary pictured in Fig. 1 of this article [1]) reveal
irus replication in patients with coronary artery disease as dem-
nstrated by the presence of the enteroviral VP1 capsid protein (1).
revious extensive investigations regarding immunohistochemical
tainings for the detection of enteroviral proteins in cardiac tissue
y applying the antibody from clone 5-D8/1 (Dako, Glostrup,
enmark), which was also applied in this study, revealed a
onsiderable unspecific cross-reaction with uninfected necrotic or
poptotic human cardiomyocytes (2). In fact, using this antibody,
e found that false positive staining of cardiomyocytes can be
etected in all kinds of cardiac diseases where affected cardiomyo-
ytes are present including patients with myocardial infarction and
oronary artery disease. Therefore, the suitability of this antibody
or the visualization of CV-B capsid proteins is questionable at
east in diseased hearts.
In addition, it is surprising that Andréoletti et al. (1) found
nteroviruses to be the only cardiotropic viral agents active in
rance. In contrast, endomyocardial biopsies in Germany consis-
ently and almost exclusively contain parvovirus B19 (PVB19) and
uman herpes virus type 6 whereas CV-B is a rare finding (3–7).
s PVB19 may lead to endothelial dysfunction (8,9) and is found
n the majority of patients with a clinical picture of acute
yocardial infarction despite a normal coronary anatomy (10), one
ight expect to find also PVB19 genomes in French patients dying
f acute myocardial infarction. Of course, there are very little data
n endomyocardial biopsy findings in German patients with acute
yocardial infarction, and it cannot be excluded that one would
nd CV-B in such a cohort.
How can this astonishing difference between endomyocardial
iopsy findings in French and German people be explained? Is
iral disease of the heart a locally restricted phenomenon? Does
V-B show a tropism for wine-drinking humans while PVB19 is
ainly attracted to beer drinkers? Is there a mechanism preventing
iruses from crossing the French-German border? Or is the
ifference not a real one, but is due to methodological differences tpolymerase chain reaction primers?) in identifying small amounts
f viral genome. Whatever the reason for this discrepancy, it is
mportant to verify the findings of Andréoletti et al. (1) in other
abs with experience in identifying very small amounts of viral
enomes in human myocardium.
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eply
ur multicentric French case-control study demonstrates for the
rst time that enteroviruses (EVs) may significantly contribute to
he pathogenesis of acute myocardial infarction (MI) (1). These
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July 1, 2008:82–4esults confirm previously published forensic evidence demonstrat-
ng that EVs could be significantly associated with sudden cardiac
nexpected death cases (2). Evidently, it has been previously
stablished that these EV cardiotropic strains did not respect
ational borders (2–5).
In this study (1), the endomyocardial detection of viral capsid
rotein 1 (VP1) by immunohistochemical technique was found to
e the best tool for the diagnosis of EV-associated heart diseases as
reviously described (4,5), and no heart tissue control samples were
P1 positive using our improved immunohistological protocols
6). The VP1 results were confirmed by molecular assays and in
ome cases by the use, after cloning, of nucleic acid sequencing of
he VP1 region (1). Moreover, none of the 20 EV-positive patients
ith acute MI and none of the 2 EV-positive subjects from the
ealthy heart control group were positive for the detection of other
ardiotropic viruses, including Epstein-Barr virus, herpes simplex
iruses, cytomegalovirus, varicella-zoster virus, adenoviruses, and
arvovirus B19, in their myocardial tissues using previously pub-
ished polymerase chain reaction techniques (1). However, 60% of
he EV-negative heart tissues of MI patients were positive for the
olecular detection of 1 or several of these cardiotropic viruses,
ncluding parvovirus B19 (not shown). These results support the
revious published data on the potential role of myocardial virus
ersistence in differential aspects of endothelial function of the
oronary microcirculation endothelial activation, and myocardial
eukocyte infiltrates (7–9). By consequence, the role of other
ardiotropic viruses including parvovirus B19-persistent infection
n the development of coronary diseases remains to be explored,
nd it, therefore, is possible that other viruses may be associated to
V cardiovascular infections and may trigger the inflammatory
rocess of chronic arteriosclerosis leading to acute MI (7).
Finally, there is no evidence of a new element of the “French
aradox” related to the way of life including wine drinking, and
hich may concern a specific cardiovascular protection against
ommon cardiotropic viruses (8). However, the French red wine is
etter than German beer for our arteries, but this drink remains to
e consumed with moderation (10).
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he Challenges of Cardiovascular
esearch in Developing Countries
e read with interest the recent article by Prabhakaran et al. (1)
eporting the results of the Global Cardiovascular Disease Re-
earch Survey. Not surprisingly, the study shows a low research
utput in developing (low-income and low-middle-income) coun-
ries. The authors postulate that a major reason for this low output
s low government spending, and they recommend that govern-
ents in these countries increase their research funding to improve
esearch output.
The issues related to research and funding in developing
ountries are complicated and multifactorial. It is easy to say that
ncreasing research funding in these countries will improve their
roductivity, and this is probably true. Yet, the implementation of
his recommendation is difficult. It is very difficult to convince
overnments in developing countries, with limited financial re-
ources, to invest in research when a significant percentage of their
opulations still does not have water and electricity supplies.
imilarly, it is very difficult for universities and hospitals to invest
n research when their financial resources can barely fulfill their
asic requirements in medical care and medical education.
Furthermore, although funding is certainly an essential compo-
ent in the advancement of research, it is not the only one.
nother very important component, which is not easy to study and
nalyze, is human resources. Performing high-quality research
equires the recruitment of established senior investigators who can
nhance research productivity and, more importantly, train young
unior investigators to sustain research activity. These high-quality
nvestigators require not only funding but also political, economic,
nd social stability. The U.S. and Europe have thousands of
nvestigators who originally came from developing countries.
hese scientists reside in the U.S. and Europe not only because of
he availability of funds but also because of political, economic, and
ocial stability that they do not have in their home countries.
